News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech


7/8/2014 7:48:22 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Versant Ventures, a California-based venture capital firm with a history of investing millions in Minnesota health care companies, has closed on $295 million for a new fund, according to a regulatory filing.

The firm, which opened a Twin Cities office in 2012, said in a regulatory filing last year it was seeking $250 million for its fifth fund. A late June filing sets a target of $300 million, which is about $200 million less than the West Coast firm's previous fund.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES